Company: BWAY
Filing Date: 2025-04-22
Form Type: F-3
Source: 0001171843-25-002378
Chunk: 10

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: F-3
Chunk 10
---
 Registration
Rights Agreement, we agreed, among other things, to file this registration statement with the SEC within three (3) business days of the
filing of our Annual Report on Form 20-F for the fiscal year ended December 31, 2024.

We are registering the resale by the selling shareholder
of the above-referenced securities in order to permit the selling shareholder to offer such securities for resale from time to time pursuant
to this prospectus. The selling shareholder may also sell, transfer or otherwise dispose of all or a portion of such securities in transactions
exempt from the registration requirements of the Securities Act, or pursuant to another effective registration statement covering those.

<div align='center'>Implications of Being a Foreign Private Issuer</div>

We report under the Securities Exchange Act of 1934,
as amended, or the Exchange Act, as a non-U.S. company with foreign private issuer status. As long as we qualify as a foreign private
issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public
companies, including: (i) the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect
of a security registered under the Exchange Act; (ii) the sections of the Exchange Act requiring insiders to file public reports of their
stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and (iii) the
rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other
specific information, and current reports on Form 8-K upon the occurrence of specified significant events.

| 2 |

<div align='center'>Corporate Information</div>

Our principal executive offices are located at 16 Hartum
Street, RAD Tower, 14th Floor, Har HaHotzvim, Jerusalem, 9777516, Israel and our telephone number is +972(2)582-4030. Our website address
is http://www.BrainsWay.com. The information on our website does not constitute part of, and is not incorporated by reference into, this
prospectus. Our registered agent in the United States is BrainsWay USA, Inc. The address of BrainsWay USA, Inc. is 95 Washington Street,
Suite 104-323, Canton, MA 02021.

| 3 |

<div align='center'>RISK FACT